BackgroundCheck.run
Search For

Jing X Shi, 37Syosset, NY

Known as:
Jing N Shi Jin G Shi
Related to:
Richard W Tong 40 Shirley W Tong 38

Jing Shi Phones & Addresses

Syosset, NY   

2450 154Th St, Whitestone, NY 11357   

Oakland Gardens, NY   

San Francisco, CA   

Stony Brook, NY   

Get Report
Control this profile

Mentions for Jing X Shi

Jing Shi resumes & CV records

Resumes

Jing Shi Photo 40

Investment Strategist

Industry:
Investment Management
Work:
Legal and General America
Investment Strategist Legal and General Jan 2015 - Jun 2016
Investment Manager Pension Insurance Corporation Nov 2008 - Oct 2014
Investment Analyst Lehman Brothers Jul 2006 - Sep 2008
Analyst Ubs Jun 2005 - Sep 2005
Summer Intern Legal and General Jun 2005 - Sep 2005
Investment Strategist
Education:
Imperial College London
Dyson School of Design Engineering
Bachelor of Engineering, Bachelors, Engineering
Skills:
Investments, Fixed Income, Portfolio Management, Alternative Investments, Financial Modeling, Due Diligence
Languages:
Mandarin
English
Certifications:
Cfa Charterholder
Wset Level 3 (Pass With Merit)
Jing Shi Photo 41

Senior Sme - Sharepoint

Location:
5919 3Rd Rd, Arlington, VA 22203
Industry:
Information Technology And Services
Work:
Business Integra Inc
Senior Sme - Sharepoint Source Selection Consulting May 31, 2016 - Oct 2017
Senior Software Consultant Loch Harbour Group Mar 2015 - May 2016
Senior Sharepoint Developer Rgs Associates, Inc. May 2014 - Feb 2015
Senior Consultant Kforce Inc Mar 2013 - May 2014
Senior Sharepoint Developer at Loch Harbour Group, Inc Eastman Kodak May 2011 - Mar 2013
Software Engineer Eastman Kodak Jun 2008 - May 2011
Software Quality Engineer Ortho Clinical Diagnostics Sep 2007 - Jun 2008
Software Test Engineer Clarkson University Jun 2005 - Aug 2006
Mcnair Research Intern
Education:
Rochester Institute of Technology 2007
Bachelors, Informatics Union College 2007
Rochester Institute of Technology 2004 - 2007
Bachelors, Bachelor of Science Union College 2003 - 2004
Bachelors, Bachelor of Science, Computer Science Murry Bergtraum High School
Union College (New York)
Skills:
Software Development, Sharepoint, C#, Visual Studio, .Net, Xml, Sharepoint Designer, Java, Javascript, Html, Html 5, Css3, Asp.net Mvc, Autoit, Mysql, Php, Python, Ruby, Agile, Agile Testing, Wix, Ruby on Rails, Cakephp, Tfs, Powershell, Microsoft Office, Office 365, Sharepoint Framework, Microsoft Powerapps, Microsoft Power Bi
Languages:
English
Mandarin
Certifications:
Ms: Programming In Html5 With Javascript and Css3 Specialist
Mcps: Microsoft Certified Professional
Mcsd: Sharepoint Applications
Mcsd: App Builder — Certified 2016
Mcsd: App Builder
Mcsa: Web Applications
License E751-2051
License E751-2046
Microsoft Certified Solutions Developer
Microsoft, License E751-2051
Microsoft, License E751-2046
Microsoft
Jing Shi Photo 42

Leasing Specialist

Location:
Flushing, NY
Work:

Leasing Specialist
Jing Shi Photo 43

Jing Shi

Jing Shi Photo 44

Performance Engineer

Work:
Pearson
Performance Engineer
Jing Shi Photo 45

Jing Shi

Jing Shi Photo 46

Jing Shi

Jing Shi Photo 47

Jing Shi

Publications & IP owners

Us Patents

Methods For Diagnosis, Prognosis And Methods Of Treatment

US Patent:
8273544, Sep 25, 2012
Filed:
Apr 8, 2011
Appl. No.:
13/083156
Inventors:
Wendy J. Fantl - San Francisco CA, US
David B. Rosen - Mountain View CA, US
Alessandra Cesano - Redwood City CA, US
Santosh K. Putta - Foster City CA, US
James R. Hackett - San Jose CA, US
Michael Walker - Mountain View CA, US
Jing Shi - Mountain View CA, US
Assignee:
Nodality, Inc. - South San Francisco CA
International Classification:
G01N 33/53
G01N 33/567
G01N 33/00
US Classification:
435 721, 435 723, 435 724, 435 614
Abstract:
The present invention provides an approach for the determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, expression markers and other criteria, and the identification of cellular subsets that exhibit correlated changes in activation within the cell population. Moreover, this approach allows the correlation of cellular activities or properties. In addition, the use of modulators of cellular activation allows for characterization of pathways and cell populations. Several exemplary diseases that can be analyzed using the invention include AML, MDS, and MPN.

Methods For Diagnosis, Prognosis And Methods Of Treatment

US Patent:
8399206, Mar 19, 2013
Filed:
Oct 22, 2010
Appl. No.:
12/910769
Inventors:
Wendy J. Fantl - San Francisco CA, US
David B. Rosen - Mountain View CA, US
Alessandra Cesano - Redwood City CA, US
Santosh K. Putta - Foster City CA, US
James R. Hackett - San Jose CA, US
Michael Walker - Mountain View CA, US
Jing Shi - Mountain View CA, US
Assignee:
Nodality, Inc. - South San Francisco CA
International Classification:
G01N 33/53
G01N 33/567
G01N 33/00
US Classification:
435 721, 435 723, 435 724
Abstract:
The present invention provides an approach for the determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, expression markers and other criteria, and the identification of cellular subsets that exhibit correlated changes in activation within the cell population. Moreover, this approach allows the correlation of cellular activities or properties. In addition, the use of modulators of cellular activation allows for characterization of pathways and cell populations. Several exemplary diseases that can be analyzed using the invention include AML, MDS, and MPN.

Direct Feedback Equalization With Dynamic Referencing

US Patent:
8634500, Jan 21, 2014
Filed:
Mar 27, 2012
Appl. No.:
13/431009
Inventors:
Zuxu Qin - Palo Alto CA, US
Rajesh Kumar - Campbell CA, US
Dawei Huang - San Diego CA, US
Jing Shi - Carlsbad CA, US
Deqiang Song - San Diego CA, US
Assignee:
Oracle International Corporation - Redwood Shores CA
International Classification:
H03K 9/00
US Classification:
375316, 341143, 375317, 375318
Abstract:
A receiver circuit includes a first slicer coupled to receive data signals from a signal path and a reference voltage from a reference voltage path that is separate from the signal path. The first slicer is configured output a logic value based on a comparison between a voltage of the data signal and the reference voltage. The receiver circuit further includes a reference voltage generator configured to generate the reference voltage. The reference voltage generator is configured to dynamically generate the reference voltage based on logic values of previously received signals during operation in a first mode. During operation in a second mode, the reference voltage generator is configured to generate and provide the reference voltage as a static voltage.

Markers For Determination Of Patient Responsiveness

US Patent:
2011024, Oct 6, 2011
Filed:
Feb 11, 2011
Appl. No.:
13/026173
Inventors:
Robert C. Axtell - Menlo Park CA, US
Lawrence Steinman - Stanford CA, US
May H. Han - Menlo Park CA, US
Brigit A. de Jong - Nijmegen, NL
Chander Raman - Birmingham AL, US
Michael Walker - Carlsbad CA, US
Jing Shi - Carlsbad CA, US
International Classification:
A61K 38/21
A61K 38/02
A61K 31/225
A61K 39/395
A61P 29/00
A61P 25/00
G06F 19/00
US Classification:
424 856, 514 11, 514547, 4241421, 702 19
Abstract:
Compositions and methods are provided for prognostic classification of inflammatory diseases, e.g. inflammatory demyelinating disease, patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. The patterns of cytokines provides for a signature pattern that can identify patients likely to benefit from therapeutic intervention as well as discriminate patients that have a high probability of responsiveness to a therapy from those that have a low probability of responsiveness. Assessment of this signature pattern thus allows improved methods of care. In one embodiment of the invention, the autoimmune disease is multiple sclerosis or neuromyelitis optica.

Markers For Determination Of Patient Responsiveness

US Patent:
2011025, Oct 13, 2011
Filed:
Feb 11, 2011
Appl. No.:
13/026181
Inventors:
Robert C. Axtell - Menlo Park CA, US
Lawrence Steinman - Stanford CA, US
May H. Han - Menlo Park CA, US
Brigit A. de Jong - Nijmegen, NL
Chander Raman - Birmingham AL, US
Michael Walker - Carlsbad CA, US
Jing Shi - Carlsbad CA, US
Tito A. Serafini - Belmont CA, US
International Classification:
A61K 39/395
A61P 3/10
A61P 11/06
G06F 19/00
A61P 1/16
A61P 25/16
A61P 9/10
A61P 3/04
A61P 29/00
A61P 11/00
US Classification:
4241421, 4241451, 702 19
Abstract:
Compositions and methods are provided for prognostic classification of inflammatory diseases, e.g. inflammatory demyelinating disease, patients into subtypes, which subtypes are informative of the patient's need for therapy and responsiveness to a therapy of interest. The patterns of cytokines provides for a signature pattern that can identify patients likely to benefit from therapeutic intervention as well as discriminate patients that have a high probability of responsiveness to a therapy from those that have a low probability of responsiveness. Assessment of this signature pattern thus allows improved methods of care. In one embodiment of the invention, the autoimmune disease is multiple sclerosis or neuromyelitis optica.

Methods For Diagnosis, Prognosis And Methods Of Treatment

US Patent:
2013003, Feb 7, 2013
Filed:
Aug 28, 2012
Appl. No.:
13/596579
Inventors:
Wendy J. Fantl - San Francisco CA, US
David B. Rosen - Mountain View CA, US
Alessandra Cesano - Redwood City CA, US
Santosh K. Putta - Foster City CA, US
James R. Hackett - San Jose CA, US
Michael Walker - Mountain View CA, US
Jing Shi - South San Francisco CA, US
Assignee:
Nodality, Inc. - South San Francisco CA
International Classification:
G01N 21/64
G01N 21/76
US Classification:
435 71
Abstract:
The present invention provides an approach for the determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, expression markers and other criteria, and the identification of cellular subsets that exhibit correlated changes in activation within the cell population. Moreover, this approach allows the correlation of cellular activities or properties. In addition, the use of modulators of cellular activation allows for characterization of pathways and cell populations. Several exemplary diseases that can be analyzed using the invention include AML, MDS, and MPN.

Possible Relatives

Dan C Shi  Dian Shi  Edward H Shi  En S Shi  Fan Y Shi  Fel K Shi  Feng I Shi  Jing M Meng  Jing H Lee  Jing P Li 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.